Kikuchi, Japan

Motoharu Abe

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Location History:

  • Kumamoto, JP (2020)
  • Kikuchi, JP (2020 - 2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Motoharu Abe: Innovator in Vaccine Development

Introduction

Motoharu Abe is a prominent inventor based in Kikuchi, Japan. He has made significant contributions to the field of vaccine development, holding a total of three patents. His work focuses on creating innovative solutions to combat viral infections, particularly dengue fever.

Latest Patents

One of his latest patents is a vaccine containing immobilized virus particles. This invention relates to a vaccine that includes fixed virus particles, wherein the summed fever response of three rabbits to these particles in a pyrogen test is less than 80% compared to the original virus particles. Another notable patent is a multivalent dengue vaccine composition, which comprises a mixture of attenuated dengue viruses from different serotypes. This highly safe dengue vaccine induces a neutralizing antibody response against all four serotypes of the dengue virus without causing excessive viremia with a single administration. The tetravalent dengue virus formulation is recognized for its excellent efficacy and safety.

Career Highlights

Motoharu Abe is currently associated with Km Biologics Co., Ltd., where he continues to advance his research in vaccine technology. His innovative approaches have positioned him as a key figure in the field of immunology.

Collaborations

He collaborates with notable colleagues, including Hiroto Onuma and Yukari Tsurudome, who contribute to his research endeavors and help drive forward the development of effective vaccines.

Conclusion

Motoharu Abe's work in vaccine development showcases his commitment to improving public health through innovative solutions. His patents reflect a deep understanding of viral infections and a dedication to creating safe and effective vaccines.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…